Growth Metrics

Tarsus Pharmaceuticals (TARS) Preferred Stock Liabilities (2020)

Historic Preferred Stock Liabilities for Tarsus Pharmaceuticals (TARS) over the last 1 years, with Q3 2020 value amounting to $103.2 million.